Description

Opdivo Nivolumab 40mg Injection: Uses, Side Effects, and Precautions

Opdivo Nivolumab 40mg Injection is an immune checkpoint inhibitor used to treat various cancers, including lung cancer, melanoma, kidney cancer, and lymphoma. It works by enhancing the immune system?s ability to detect and fight cancer cells.

Dosage and Administration
Given as an intravenous infusion by a healthcare professional.
Dosage depends on the type of cancer and patient response.
Typically administered every 2 to 4 weeks.

Common Side Effects

Fatigue and weakness
Nausea and vomiting
Skin rash and itching
Diarrhea or constipation

Serious Side Effects

Severe immune-related reactions affecting lungs, liver, or intestines
Endocrine gland dysfunction (thyroid, adrenal glands)
Severe infusion reactions (fever, chills, difficulty breathing)
Liver toxicity (jaundice, dark urine)

Precautions and Warnings

Regular monitoring of liver and kidney function is required.
May cause immune-related side effects requiring corticosteroid treatment.
Not recommended during pregnancy or breastfeeding.
Use with caution in individuals with autoimmune disorders.

Disclaimer:

Products information mentioned on this site is for informative purposes only. The product image belongs to the respective company. Genetec Lifesciences is a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.